We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Showcases the Future of Diagnostic Solutions at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 11 Apr 2022
Print article
Image: cobas® pulse system (Photo courtesy of Roche Diagnostics)
Image: cobas® pulse system (Photo courtesy of Roche Diagnostics)

Roche Diagnostics (Basel, Switzerland) showcased its next generation diagnostics solutions that deliver fast and accurate results to help clinicians improve patient care and help reduce the healthcare burden at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicines (EUROMEDLAB) in Munich, Germany.

These included the cobas 5800 System that expands access to PCR testing with meaningful and timely results to more patients across the globe, and a new handheld glucose management device, the cobas pulse, powered by the cobas infinity edge suite, that equips healthcare professionals with expanded digital capabilities at the point of care. An evaluation of the recently launched AVENIO Tumour Tissue Comprehensive Genomic Profiling (CGP) Kit for oncology research was also presented. The kit helps expand access to genomic profiling globally, supporting researchers in navigating the complex landscape of cancer research. The findings assess genomic results generated across multiple CGP workflows for variants that are known to cause and drive cancer.

Roche also hosted its very own highly interactive booth, where attendees visited and experienced how the company is helping to improve healthcare. Highlights from the booth included an integrated diagnostics lab and data analytics tools that guide the decision-making process toward optimizing lab operations, customer delivery, and overall lab performance in a targeted and efficient manner. There was also a special interactive area at the booth highlighting Roche’s COVID-19 response. Those unable to attend the congress in person were able to view and engage in the virtual booth via an online portal, with Ro_Bot, a virtual character, as host: Roche EUROMEDLAB 2021. Those joining online were able to follow key sessions via livestream, at no cost. During the congress, Roche also facilitated discussions on key topics in diagnostics today, including three educational workshops.

“Roche is committed to developing innovative solutions that equip healthcare professionals with the tools that allow for earlier diagnosis and more personalized treatment, optimizing patient care and leading to better outcomes,” said Ann Costello, Global Head, Roche Diagnostics Solutions. “We are proud to work in partnership with healthcare professionals across many disease areas and disciplines to enable better healthcare decisions.”

“Lab medicine has always played a key role in healthcare, as proven during the Covid-19 pandemic,” added Moritz Hartmann, Global Head of Roche Information Solutions. “We are working with industry leaders worldwide on digital health solutions to facilitate data-driven decision-making in any setting. This includes labs, clinics and homes with the ultimate goal to improve care for each patient and reduce inefficiencies in healthcare delivery.”

Related Links:
Roche Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Pathology

view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more

Industry

view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.